Impact of COVID-19 on prevalence of community pharmacies as CLIA-Waived facilities
| العنوان: | Impact of COVID-19 on prevalence of community pharmacies as CLIA-Waived facilities |
|---|---|
| المؤلفون: | Donald G. Klepser, Nicklas S. Klepser, Alex J. Adams, Michael E. Klepser, Jennifer L. Adams |
| المصدر: | Research in Social & Administrative Pharmacy Research in Social and Administrative Pharmacy |
| بيانات النشر: | Elsevier Inc., 2020. |
| سنة النشر: | 2020 |
| مصطلحات موضوعية: | Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Point-of-care testing, Pharmaceutical Science, Pharmacy, 01 natural sciences, Article, 03 medical and health sciences, 0302 clinical medicine, Pandemic, Prevalence, medicine, Humans, 030212 general & internal medicine, 0101 mathematics, Pandemics, CLIA-Waived laboratories, Human services, health care economics and organizations, Pharmacies, Community pharmacies, SARS-CoV-2, business.industry, 010102 general mathematics, COVID-19, medicine.disease, Waiver, United States, Medical emergency, business, Community pharmacy |
| الوصف: | Background The Clinical Laboratory Improvement Amendments of 1988 (CLIA) enabled greater access to low-risk tests by allowing their use in facilities with a Certificate of Waiver in the U.S. Recently, the 2019 novel coronavirus (COVID-19) pandemic has shined a spotlight on CLIA-waived diagnostic testing. To meet this increased patient demand for diagnostic testing, the U.S. Department of Health and Human Services (HHS) authorized licensed pharmacists to order and administer FDA authorized COVID-19 tests. Objective This study aims to update the previous national benching report and examine both the number of pharmacies in the United States with CLIA Certificates of Waiver before and after the SARS-CoV-2 pandemic and the state-by-state differences in the percentage of pharmacies with CLIA Certificates of Waiver. Methods Data were collected from the U.S. Centers for Disease Control and Prevention CLIA Laboratory Search website May 3rd, 2015, August 4th, 2019 and November 26th, 2020. The website allows for exportation of demographic data on all CLIA-waived facilities by state. Results Pharmacies exhibited the largest growth both in number (4865 new locations) and by percent (45%) of CLIA-waived facilities between 2015 and 2020. The total number of pharmacies with a CLIA-waiver grew from 10,626 (17.94%) locations in 2015 to 12,157 (21.43%) locations in 2019, to 15,671 (27.63%) locations in 2020. States demonstrated considerable variability in the percentage of pharmacies with a CLIA-waiver, with a range of 2.92%–56.52%. Conclusions Pharmacies have become an increasingly important location for patients to access CLIA-waived tests in the United States, now serving as the second largest provider of CLIA-waived tests by the total number of locations. Most of this growth occurred between 2019 and 2020 due to the COVID-19 pandemic, and concentrated efforts will be necessary to sustain this momentum. |
| اللغة: | English |
| تدمد: | 1934-8150 1551-7411 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1017808a1d0f878bbb99788d010f9873Test http://europepmc.org/articles/PMC7737532Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....1017808a1d0f878bbb99788d010f9873 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 19348150 15517411 |
|---|